White Powder made in South Korea, Suitable for each Pharmacopoeia (USP, JP, IP, Ph.Eur)
Primarily used to reduce the risk of organ rejection in patients with allogeneic organ transplantation. It is also used to treat autoimmune diseases, such as atopic dermatitis.
Tacrolimus is a polyketide macrolide lactone with immunosuppressive activity.
Tacrolimus is a highly potent immunosuppressant. Compared to a similar immunosuppressant cyclosporine, tacrolimus has been shown to be 10 to 100 times more potent and have less side effects, such as hypertension, hirsutism and gingivalhyperplasia.
Since 2003, Ceres F&D has researched industrial technologies for microbial bioactive substances biological active substance to develop high-production fermentations strains for industrial production of tacrolimus (patent no. 2007-0082624), high-purity processes suitable for pharmaceutical standards (patent no. 2008-00915, 2008-0091521), genetic biosynthesis of tacrolimus (patent no. 2008-00118854), and analysis methods of tacrolimus and its related substances. Based on these patented technologies, in 2009, we registered and scaled up from lab scale to plant scale for commercial production of tacrolimus.
For pharmaceutical preparation and manufacture only If there is an example of a single system, refer to the single system 'Cautions for Use'.
Storage and Handling Precautions
1. Carefully store on temperature, sunlight, humidity, and others.
2. Put in the original container and keep it closed. (Taking out of the original container and store in another container may cause an accident caused by misuse or deterioration of the medication quality).
Biopharmaceutical company producing immunosuppressants and antibiotics
Located in Jecheon-si, South Korea, our manufacturing site is cGMP certified and operates according to the highest production and quality standards. With separate production lines for immunosuppressants and antibiotics, our facilities are designed to maximize efficiency and quality while minimizing risk.